Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer

Shaomin Zou,Chao Yang,Jieping Zhang,Dan Zhong,Manqi Meng,Lu Zhang,Honglei Chen,Lekun Fang,Honglei Chen and Lekun Fang

DOI: https://doi.org/10.1186/s12967-024-04984-4

IF: 8.44

2024-02-19

Journal of Translational Medicine

Abstract:Colorectal cancer (CRC) is the leading cancer worldwide. Microbial agents have been considered to contribute to the pathogenesis of different disease. But the underlying relevance between CRC and microbiota remain unclear.

medicine, research & experimental

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve

This paper primarily explores the relationship between colorectal cancer (CRC) and the gut microbiome, aiming to uncover the role of the microbiome in the pathogenesis of CRC. Specifically:

1. **Relationship between the Microbiome and CRC**:
- Through multi-omics analysis (including metagenomics, genomics, and transcriptomics), researchers aim to understand the changes in specific gut microbes in colorectal cancer patients and their correlation with clinical phenotypes.
- The study identified some bacteria species associated with CRC, such as *Fusobacterium nucleatum* and *Bacteroides fragilis*, and explored how these microbes influence host metabolic pathways.

2. **Association between Mutated Genes and the Microbiome**:
- By performing high-throughput sequencing on fecal and tissue samples from 41 CRC patients, researchers identified four significantly mutated genes: TP53, APC, KRAS, and SMAD4.
- Further analysis revealed a significant correlation between these mutated genes and specific microbial species. For example, the abundance of *Butyricicoccus pullicaecorum* was significantly reduced in TP53 mutation carriers.

3. **Impact of the Microbiome on the Immune Environment**:
- The study also explored the impact of the microbiome on the tumor immune microenvironment. Specifically, *Fusobacterium nucleatum* was found to alter the state of immune cells by regulating TNFSF9 gene expression, thereby promoting tumor development.
- Immune cell types (such as dendritic cells and CD8+ T cells) exhibited different trends in CRC patients, indicating the important role of the immune microenvironment in CRC progression.

In summary, this paper aims to comprehensively analyze the characteristics of the gut microbiome in CRC patients and its complex interactions with host gene mutations and the immune microenvironment through multi-omics approaches, with the goal of discovering new biomarkers for early detection and diagnosis of CRC.